Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?

被引：4
|
作者：
Kucharz, Eugeniusz Jozef [1 ]
Kotulska-Kucharz, Anna [1 ]
机构：
[1] Med Univ Silesia, Dept Internal Med Rheumatol & Clin Immunol, 45-47 Ziolowa St, PL-40635 Katowice, Poland
来源：
REUMATOLOGIA | 2021年 / 59卷 / 02期
关键词：
D O I：
10.5114/reum.2021.105438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：65 / 67
页数：3
相关论文
共 50 条
  • [31] Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure
    Yan Jiang
    Oliver Lin
    Sidhartha R. Sinha
    Digestive Diseases and Sciences, 2017, 62 : 1597 - 1606
  • [32] Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease
    Decourt, Boris
    Lahiri, Debomoy K.
    Sabbagh, Marwan N.
    CURRENT ALZHEIMER RESEARCH, 2017, 14 (04) : 412 - 425
  • [33] Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors
    Bergman, MR
    Holycross, BJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (01): : 247 - 254
  • [34] ADHERENCE EVALUATIONS FOR TUMOR NECROSIS FACTOR ALPHA INHIBITORS FOR RHEUMATOID ARTHRITIS I
    Watanabe, J. H.
    Saseen, J. J.
    Dilokthomsakul, P.
    Campbell, J. D.
    VALUE IN HEALTH, 2017, 20 (05) : A148 - A148
  • [35] Tumor necrosis factor-alpha inhibitors and acne fulminans: Friend or foe?
    Barry, Kelly K.
    Neale, Holly D.
    Hawryluk, Elena B.
    PEDIATRIC DERMATOLOGY, 2023, 40 (04) : 678 - 680
  • [36] METALLOPROTEINASE INHIBITORS BLOCK PROCESSING AND SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA
    NICHOLS, JS
    BECHERER, JD
    BAST, RC
    BOYER, CM
    CHAMPION, B
    FURDON, P
    MCELROY, A
    PAYNE, A
    TAYLOR, JD
    VERGHESE, M
    WARNER, J
    WU, S
    WAYS, JP
    MCGEEHAN, GM
    FASEB JOURNAL, 1994, 8 (07): : A1361 - A1361
  • [37] The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis
    Victoria Hernandez, Maria
    Sanmarti, Raimon
    Canete, Juan D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 613 - 624
  • [38] Utilization of Tumor Necrosis Factor alpha Inhibitors (TNFi) in Patients with Ankylosing Spondylitis
    He, Jinghua
    Watson, Douglas J.
    Peloso, Paul M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 42 - 42
  • [39] Use of Tumor Necrosis Factor Alpha Inhibitors for Treatment of Refractory Cardiac Sarcoidosis
    Wand, Alison L.
    Okada, David
    Griffin, Jan M.
    Tandri, Harikrishna S.
    Chrispin, Jonathan
    Sheikh, Farooq H.
    Kasper, Edward K.
    Chen, Edward
    Gilotra, Nisha A.
    CIRCULATION, 2019, 140
  • [40] Phytochemicals as inhibitors of tumor necrosis factor alpha and neuroinflammatory responses in neurodegenerative diseases
    Zahedipour, Fatemeh
    Hosseini, Seyede Atefe
    Henney, Neil C.
    Barreto, George E.
    Sahebkar, Amirhossein
    NEURAL REGENERATION RESEARCH, 2022, 17 (08) : 1675 - 1684
12345